21 matches for your search in the start-up spotlight
rss
DMC seeking to transform how the world makes chemicals
16-Jan-2025
DMC Biotechnologies announced the appointment of Dr. James (Jim) Flatt as Chief Executive Officer, effective immediately. Dr. Flatt brings more than 30 years of leadership experience in biotechnology and biomanufacturing. He has a proven track record of delivering commercial success through ...
Preparations for upcoming clinical trials in the USA are ongoing
23-Oct-2024
HepaRegeniX GmbH, a clinical stage company developing a novel regenerative therapy for the treatment of acute and chronic liver diseases, announced the appointment of Dr. Martin Bonde as its new Chair of the Board of Directors, effective immediately. His appointment follows the recent €15 million ...
Elias Papatheodorou moves from Chair of the Board to CEO of HepaRegeniX
15-Jul-2024
HepaRegeniX GmbH, a clinical stage company developing novel regenerative therapies for the treatment of acute and chronic liver diseases, announced the closing of a Series C round led by Vesalius Biocapital IV with participation of existing investors Novo Holdings, Boehringer Ingelheim Venture ...
07-Mar-2024
Electrochaea is strengthening its management team with two new additions. Tim Baack is the new Chief Commercial Officer (CCO) and Karsten Hanich is the new Chief Financial Officer (CFO). Electrochaea's project pipeline is filling with projects and all eyes are on growth. Before joining ...
09-Nov-2023
Cellbox Solutions GmbH announced that Dr. Hartmut Tintrup has joined Cellbox Solutions GmbH as Chief Executive Officer. Hartmut joins the Cellbox team from Lonza, where he served as Global Head Business Development in the Cell & Gene Technologies Business Unit. He brings more than 20 years of ...
Proactive and analytical problem solver
25-Oct-2023
Hy2gen, the global developer, owner and operator of facilities for the production of renewable hydrogen and hydrogen derivatives welcomes Julien Marteau as new Managing Director for the French subsidiary Hy2gen France SAS. Julien has more than 18 years of experience in building and managing ...
Founder will be stepping down as CEO
09-May-2023
LenioBio GmbH, the Düsseldorf-based cell-free protein expression company, has announced that its founder and CEO, Dr. Remberto Martis, will be stepping down as CEO and has proudly named his successor as André Goerke, starting June 1st, 2023 André has previously held senior positions in ...
15-Mar-2023
Nobell Foods, the company pioneering the use of Plant-Grown Proteins to create animal-free cheese, announced the hire of Sergey Solomatin as the company's new Vice President of Food Science and Product Development. Solomatin joins the company after more than 10 years at Impossible Foods, where he ...
Leading Vegan Cheese Maker Commences CEO Search and Sets Innovation Pipeline for 2023
22-Feb-2023
Leading plant milk dairy maker, Miyoko’s Creamery, announces today that the company and its founder Miyoko Schinner have parted ways as the company enters a new stage of growth. With this, Miyoko has exited as CEO and is no longer involved in day-to-day operations. Miyoko’s Creamery has partnered ...
10-Jan-2023
California-based Impossible Foods today announced that it has hired top consumer goods industry leader Sherene Jagla as its first Chief Demand Officer. Jagla will join the food and climate company this month to bring its sales, marketing, insights and product development teams into one integrated ...
